A COVID-19 Drug Could Be Creating More Variants With Distinct Variations

COVID-19 viruses with distinctive patterns of mutation are appearing in countries and in people who have used a Merck drug called molnupiravir.  The drugs being created to “help” the slave class with the “pandemic” are now helping to cause mutations and prolong it.

Despite previous warnings from scientists that this drug could have seriously harmful side effects like causing cancers and birth defects,

There are researchers who believe that the risk of these mutagenic drugs generating potentially dangerous new variants outweighs their benefits. Animal studies suggest molnupiravir might also cause DNA mutations in those taking it, which is why it isn’t given during pregnancy, or if a potential recipient is trying to get pregnant or is breastfeeding.

Merck Asks FDA For Emergency Approval Of New COVID Drug Despite Safety Concerns

The $700 course of the pill is meant to be taken at home as four capsules twice a day for five days, constituting a total of 40 pills. Per the trial data released by Merck – which was greeted with fawning from doctors and scientists – it halved hospitalizations and deaths (though the trial was cut short by a supervisory board who claimed the data was so positive it would be unethical to withhold the drug from the placebo group). The approval could come within weeks, per the NYT. -ZeroHedge

Molnupiravir, a drug used to treat COVID-19 appears to be driving the evolution of the SARS-CoV-2 coronavirus, according to an analysis of the 15 million viruses sequenced around the world so far. The analysis found around 900 viruses with distinctive patterns of mutation that probably arose in people being treated with the drug. In at least a few cases, these viruses appear to have spread from the person being treated to others, but no variants of concern have any of these patterns.

“The signal is pretty clear and there aren’t variants of concern that have those signals,” says Theo Sanderson at the Francis Crick Institute in London.

Molnupiravir works by inducing so many mutations in RNA viruses, such as SARS-CoV-2, as they replicate in a person’s body that the viruses lose the ability to replicate and die out. But before the viruses are eliminated from a person’s body, there is a risk of them spreading to others. -New Scientist

So it’s totally fine if the big pharmaceutical companies create new variants, but the slave class has to wear face masks and obey in order to stay healthy?

A spokesperson for Merck, the company that makes molnupiravir, says that this study relies on circumstantial associations. “The authors assume these mutations were associated with viral spread from molnupiravir-treated patients without documented evidence of that transmission… Furthermore, these sequences were uncommon and were associated with sporadic cases.”

Now big pharma is concerned with how studies are conducted. Pfizer and Moderna don’t seem to care that they commit scientific fraud regularly.

SCIENCE FRAUD: Pfizer’s COVID Jab “Placebo” Control Group Was Given MODERNA’s “Vaccine”

In most cases, the scientists who worked on this study couldn’t establish that these new mutations were transmitted to others. However, they did identify a few clusters that were able to infect others, including one in Australia, where it seemed to have been spread from person to person.

This article has been contributed by SHTF Plan. Visit www.SHTFplan.com for alternative news, commentary and preparedness info.